-
Ultralife Corporation to Report First Quarter Results on April 27, 2023
ソース: Nasdaq GlobeNewswire / 13 4 2023 07:00:00 America/New_York
NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023.
Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on April 27, 2023. Please see the call-in procedures which follow below.
NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE:
To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link: https://register.vevent.com/register/BId33ee3ac5fa74d2e946203064e7fb772 prior to the call. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again.
A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
Company Contact: Investor Relations Contact: Ultralife Corporation LHA Philip A. Fain Jody Burfening (315) 210-6110 (212) 838-3777 pfain@ulbi.com jburfening@lhai.com